Insulin syringes market was valued at $1,561.20 million in 2020, and is projected to reach $2,401.51 million by 2030, CAGR of 4.4% from 2021 to 2030
— Allied Market Research
WILMINGTON, OREGON, UNITED STATES, February 16, 2024 /EINPresswire.com/ — An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes. The needle is usually thin and short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. it serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Further, the size of the insulin syringes market is selected based on the desired dosage of insulin to be administered to diabetic patients.
The insulin syringes market size is studied on the basis of syringe size, disease type end user and region to provide a detailed assessment of the market. On the basis of syringe size, it is bifurcated into 3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml) and 1cc syringe (1ml). On the basis of disease type, it is bifurcated into type -1 diabetes and type-2 diabetes. By end user, it is bifurcated into hospital, homecare setting, and nursing homes. by region the market is bifurcated into North America, Europe, Asia-Pacific and LAMEA.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/3740
On the basis of syringe size, 3c/10 cc syringes(0.3ml) segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as increase in use of 3/10cc syringes (0.3ml) due to rise in the prevalence of Type 1diabetes across the world are the key factor anticipating the growth of market.
On the basis of disease type, type 2 diabetes segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as rise in the adoption of unhealthy lifestyles surge in prevalence of type diabetes across the world are the key factor anticipating the growth of market.
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/insulin-syringes-market/purchase-options
On the basis of end user, hospital & clinics segment holds the largest share in market in 2020 The growth of the segment is attributable to the factors such as rise in geriatric population and large patients pool and surge in prevalence type 2 diabetes across the world, which require the administration of insulin with the help of insulin syringes are the key factor anticipating the growth of market.
🔘 𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
✔️ On the basis of syringe size, the 3/10cc syringe segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
✔️ On the basis of end user, the hospital & clinics industries segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
✔️ Region wise, North America is held the largest market share in 2020, and is expected to remain dominant throughout the forecast period
✔️ Asia-Pacific is anticipated to grow at the highest rate in the insulin syringes market during the forecast period, followed by LAMEA
🎯 𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/3740
🔘 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
▪️ Novo Nordisk A/S
▪️ Biocon Ltd Abbott Laboratories
▪️ Terumo Corporation
▪️ Cardinal Health Inc
▪️ Beckton and Dickinson Company
▪️ Eli Lilly and Company
▪️ Nipro Medical Corporation
▪️ Medline Industries and Hindustan syringe and medical device Ltd
🔘 𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 :
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
🔘 𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
USA/Canada (Toll Free):
+1–800–792–5285
UK: +44–845–528–1300
Hong Kong: +852–301–84916
India (Pune): +91–20–66346060
Fax: +1–800–792–5285
[email protected]
Web:
www.alliedmarketresearch.com
Allied Market Research Blog:
https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube |
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Article originally published on www.einpresswire.com as Insulin Syringes Market to reach $2,401.51 million by 2030, at CAGR of 4.4%